title: Rapid diagnosis of extensively drug-resistant tuberculosis by use of a reverse line blot hybridization assay.
abstract: Drug resistance in tuberculosis (TB) is a matter of grave concern for TB control programs, as there is currently no cure for some extensively drug-resistant (XDR) strains. There is concern that this resistance could transmit, stressing the need for additional control measures, rapid diagnostic methods, and newer drugs for treatment. We developed an in-house assay that can rapidly detect resistance to drugs involved in the definition of XDR-TB directly from smear-positive specimens. Two hundred fifteen phenotypically XDR-TB isolates and 50 pansusceptible isolates were analyzed using a reverse line blot hybridization (RLBH) assay. The assay was also successfully applied to 73 smear-positive clinical specimens. The RLBH assay exhibited good sensitivity for the detection of resistance to isoniazid (99%), rifampin (99%), fluoroquinolones (95.3%), and second-line aminoglycosides (94.8%). The results from application of this assay on direct smear-positive clinical specimens revealed 93% concordance with the phenotypic drug susceptibility test (DST) results for the above-mentioned drugs. The time to accurate DST results was significantly reduced from weeks to 3 days. This molecular assay is a highly accurate tool for screening for XDR-TB, which achieves a substantial reduction in diagnostic delays.
authors: Department of Research, PD Hinduja National Hospital and Medical Research Centre, Mumbai, India.
authors: Kanchan
authors: K
authors: Ajbani
authors: Anjali
authors: A
authors: Shetty
authors: Ajita
authors: A
authors: Mehta
authors: Camilla
authors: C
authors: Rodrigues
references: N Engl J Med. 2010 Sep 9;363(11):1005-15
references: 20825313
references: J Clin Microbiol. 1998 May;36(5):1220-5
references: 9574680
references: J Clin Microbiol. 2011 Apr;49(4):1588-90
references: 21289142
references: Indian J Med Microbiol. 2009 Jul-Sep;27(3):217-21
references: 19584501
references: J Clin Microbiol. 1997 Mar;35(3):719-23
references: 9041419
references: Clin Microbiol Rev. 1995 Oct;8(4):496-514
references: 8665467
references: J Clin Microbiol. 2005 Jun;43(6):2996-7
references: 15956443
references: J Clin Microbiol. 2005 Nov;43(11):5477-82
references: 16272473
references: J Microbiol Methods. 2004 Jun;57(3):323-35
references: 15134881
references: Nucleic Acids Res. 1991 Jul 25;19(14):3929-33
references: 1861985
references: J Clin Microbiol. 2000 Sep;38(9):3194-9
references: 10970356
references: Antimicrob Agents Chemother. 2010 Nov;54(11):4789-93
references: 20713679
references: Lancet. 2010 May 22;375(9728):1830-43
references: 20488523
references: J Clin Microbiol. 2010 Aug;48(8):2934-9
references: 20573868
references: Int J Tuberc Lung Dis. 2006 Aug;10(8):838-43
references: 16898366
references: J Clin Microbiol. 1997 Oct;35(10):2521-5
references: 9316900
references: Antimicrob Agents Chemother. 1995 Aug;39(8):1700-3
references: 7486904
references: Int J Infect Dis. 2009 Jan;13(1):46-58
references: 18565777
references: J Clin Microbiol. 2004 Oct;42(10):4438-43
references: 15472290
references: Antimicrob Agents Chemother. 2005 Aug;49(8):3192-7
references: 16048924
references: PLoS One. 2007 Aug 22;2(8):e757
references: 17712405
references: Lancet Infect Dis. 2003 Jul;3(7):432-42
references: 12837348
references: Antimicrob Agents Chemother. 1994 Apr;38(4):773-80
references: 8031045